Nitrogen mustard was first used in the treatment of the nephrotic syndrome eighteen years ago (Chasis et al. 1949) but was soon to be superseded by corticosteroids. After more than fifteen years, however, it has become apparent that steroid therapy is by no means a perfect treatment for children with the nephrotic syndrome. In a tenyear follow-up study Cornfeld & Schwartz (1966) found that the mortality approached 25 %. Arneil & Lam (1966) recently reported their findings in 45 nephrotic children treated with prednisolone and followed up for not less than five years. Fiftythree per cent of patients relapsed after initially responding to treatment and 7 % failed to respond at all. Unfortunately they were unable to correlate the steroid response in their patients with either the selectivity of proteinuria (Cameron & White 1965) or renal biopsy findings. They did, however, observe a greatermortality and incidence of persistent proteinuria in children who had macroscopic heematuria at onset. Such patients often have a serious form ofproliferative glomerulonephritis (GN) and, because they may actually be harmed by steroid therapy (White et al. 1966) , it is desirable that a complete diagnosis should, whenever possible, be made before starting treatment.
Renal Morphology and Steroid Response
While it is not the purpose of this paper to discuss at length the renal morphology in the nephrotic syndrome, a brief reference is nevertheless appropriate, since the patterns of steroid response are related to the glomerular changes. Table 1 shows the findings in renal biopsy specimens obtained from 136 children by Dr J S Cameron and myself, all of them examined personally by light microscopy. They will be published in detail--in a later paper. Seventy-eight children were biopsied before treatment and form an unselected series. The remaining 58 children were referred on account of diagnostic or therapeutic problems, and include a high proportion of patients with severe proliferative and chronic GN.
Some of the patients are participants in a controlled investigation of -steroid therapy which precludes detailed interim analysis, and follow-up data are at present incomplete. However, from information derived from 93 of the 136 children certain generalizations can be made. There appears to be no distinction, other than on histological grounds, between patients showing 'minimal changes' and those showing mild proliferative GN. Indeed it is sometimes difficult to place an individual biopsy specimen confidently in either category, and two pathologists will often hold different opinions. The clinical presentations in both groups are similar, hmmaturia being absent or minimal; the proteinuria is highly selective; and while the majority of patients initially respond to steroids, a high proportion run a relapsing course. Mesangial thickening and hypercellularity, seen in 22% of biopsies from the 78 unselected nephrotic children, were found by Jennings & Earle (1961) to be characteristic of both resolving and early chronic post-streptococcal nephritis. Proteinuria is moderately or highly selective and may continue longer than it does in the first two groups of children, but a relapsing course is less common and most cases appear to recover.
In the severe form, proliferation is diffuse and accompanied by either epithelial hyperplasia with crescent formation, or capillary wall thickening, or both. Sinister clinical features, such as hvmaturia, hypertension and azotmemia are common; the proteinuria is poorly or, at most, moderately selective; there is no useful response to steroid therapy and recovery is rare. The disease may be rapidly destructive but more often progresses to chronic nephritis.
Membranous change is rare in childhood ( Table  1) ; claims that 'mixed' membranous and proliferative forms exist (Todd & Bouton 1965) possibly arise out of misconceptions based on inadequate staining methods. The hmmatoxylin and eosin (HE) and periodic acid-Schiff (PAS) methods do not clearly distinguish the subendothelial deposits of severe proliferative GN from the subepithelial deposits which characterize membranous change. Good periodic acid-silver methenamine (PASM) stains, on the other hand, reveal that the capillary wall thickening accompanying severe prolifer-ative GN is due to subendothelial deposits of fine fibrillar and hyaline material, and that the true basement membrane is not thickened (Fig 1) .
The Problems By combining these clinicopathological correlations with Arneil & Lam's (1966) five-year prednisolone results, some reasonable assumptions can be made, and it is apparent that there are two main problems:
(1) Patients who show no initial steroid response: Of the 78 unselected patients in the present series, 8 % would be expected to show no response to steroids. In fact Arneil & Lam (1966) found that 7% of their children did not respond. The prognosis in these cases is grave and the aim of treatment is to prolong or, if possible, to save life. In nephrotic children presenting with htmaturia at onset, steroids are better withheld until creatinine and differential protein clearances have been determined and a renal biopsy carried out, to assess the nature and severity of the lesion.
(2) Patients who initially respond to steroids but relapse frequently and become 'steroid dependent': Follow-up data on 30 of the unselected children showing minimal changes or mild proliferative GN reveal that 12 have relapsed occasionally and 12 (40 %.) frequently. Since these two groups form 69 % of the 78 unselected children, approximately 30 % of childhood nephrotics may be expected to become steroid dependent. Arneil & Lam (1966) suggested that, of the 53 % of cases who relapsed after initial treatment, those who did so three times within a year might be considered suitable for immunosuppressive therapy. The ultimate mortality rate of this group following treatment with prednisolone has not been defined, although Arneil & Lam (1966) believe that it will be less than with earlier steroids. The immediate aim of alternative treatments is thus to minimize the toxic effects of prolonged steroid therapy, especially the retarding effect on growth.
Results of Cytotoxic Drug Therapy Severe proliferative glomerulonephritis: The initial results of treatment with azathioprine or cyclophosphamide in 13 children and 5 adults have been reported previously (White et al. 1966 ). Improvement occurred in 12 patients and the results were good in children with anaphylactoid purpura complicated by the nephrotic syndromean association which frequently signifies a grave prognosis (Lagrue et al. 1962) . Azathioprine was selected initially because of its established role in the prevention of homograft rejection (Calne et al. 1963 ) but cyclophosphamide was later used after alarmingly severe and prolonged leucopenia was observed in 2 patients.
The results of treatment in a further 6 patients with the nephrotic syndrome due to proliferative GN can be seen in Table 2 . Cases 1-4 had severe proliferative GN with capillary wall thickening due to subendothelial deposits. A representative glomerulus from Case 2 is shown in Fig 1. This is the lesion which West, McAdams, McConville, Davis & Holland (1965) have associated with persistently low serum P c-globulin levels and which they have termed 'hypocomplementemic persistent glomerulonephritis'. In the present series P,ic-globulin levels were determined at Guy's Hospital, London, by Dr J S Cameron and were found to be lowered in Cases 2-4. The proteinuria 'selectivity index' (Cameron & Blandford 1966 ) was in the low range. Cases 1, 3 and 4 had previously received steroids, but without avail. In all 4 children cytotoxic drugs were given together with prednisolone. Cyclophosphamide was used in 3 patients and appeared to have no effect. Case 3 also received hydroxychloroquine but this, too, was ineffective. However, Cases 2 and 4 showed some reduction of proteinuria and improvement in renal function while receiving azathioprine. The progress of Case 2 is illustrated in Fig 2, from which it can be seen that azathioprine caused a fall in the serum protein levels concurrently with the leucopenia and diminution of proteinuria, suggesting that protein synthesis is affected by the drug. Following discontinuation of azathioprine the proteinuria has persisted, but in smaller quantities, and the serum protein and P,Bc-globulin levels have risen to normal.
In Case 5 the renal biopsy showed a moderately severe proliferative GN, with lobular stalk thickening and widespread tubular atrophy but without capillary wall thickening. His nephrotic syndrome had failed to respond to steroids but a complete remission occurred during a seven-months' course of cyclophosphamide. He is now well and off all treatment.
Striking improvement occurred in Case 6, a 5-year-old boy with anaphylactoid purpura who had a transient nephrotic syndrome before treatment began. A renal biopsy showed diffuse proliferative glomerulonephritis without crescents or capillary wall thickening. The proteinuria disappeared spontaneously but macroscopic hematuria was still present five months after onset, and his creatinine clearance (Ccr) remained unchanged, at 41 ml/min/1 73m2. During a nineweek course of cyclophosphamide his Ccr rose to 93 ml/min/1 73m2 and the hiematuria almost disappeared. A repeat renal biopsy obtained four months after completion of treatment showed considerable resolution of the proliferative changes, which were now slight and confined to the lobular stalks.
Steroid-dependent nephrotic syndrome: The early results of cyclophosphamide therapy in 6 children Table 2 Results of cytotoxic drug therapy in patients with severe proliferative glomerulonephritis with relapsing nephrotic syndromes are shown in Table 3 . Their proteinuria was highly selective. Three showed minimal changes in renal biopsy specimens, and 3 showed mild proliferative GN. All 6 were dependent upon maintenance steroid therapy to prevent relapses but Cases 9 and 12 also developed late steroid resistance. Treatment began with a dose of 5 mg/kg/day but was usually reduced to about 2 mg/kg/day when the white blood count fell below 4,000/c.mm, the aim being to maintain a leucopenia while avoiding a fall of neutrophils below 1,000/c.mm. Five children responded to treatment with cyclophosphamide, the only exception (Case 9) being a familial nephrotic with an onset at the age of 11 months, Table 3 Results of cyclophosphamide therapy in steroiddependent nephrotic children who subsequently showed a similar lack of response to indomethacin. Steroids were withdrawn under cover of cyclophosphamide in all 5 patients who responded, and cyclophosphamide was discontinued after a further three or four weeks. A typical response, that of Case 10, is illustrated in Fig 3. Case 11 relapsed after five weeks but the other 4 patients have so far remained well.
Discussion
The good responses in Cases 5 and 6, together with the results reported previously (White et al. 1966) , suggest that cytotoxic drug therapy represents an advance in the treatment of persistent, steroid-resistant proliferative GN with normal or focally thickened capillary walls, including the more severe examples of anaphylactoid nephritis. The results are less impressive, however, in the severe (hypocomplementtemic) variety with diffuse capillary wall thickening, and are in keeping with the findings of . Although Cases 2 and 4 apparently improved under the influence of azathioprine, it should be emphasized that both patients had illnesses of shorter duration before treatment, and received more prolonged cytotoxic therapy than Cases 1 and 3. In a disease known to be progressive these factors must obviously be considered before other cytotoxic or anti-inflammatory drugs are judged ineffective, and there exists a need for further controlled studies. The dramatic early response to cyclophosphamide treatment witnessed in 5 out of 6 steroid-dependent nephrotic children is particularly gratifying. Cases 7-11 were chosen for treatment because they had previously required continuous steroid therapy for six to ten years in order to maintain a state of clinical remission; Cases 8 and 9 were severely stunted, with retarded skeletal ossification. Much longer follow-up is required before firm conclusions can be drawn, and a more detailed report of these and other patients will be published later. However, West et al. (1966) have recently reported remissions of ten to thirty-one months in similar patients treated with cyclophosphamide.
Alopecia is a frequent but temporary sideeffect in children receiving cyclophosphamide. Treatment was discontinued in Case 5 when he developed hematuria, probably due to chemical cystitis (Rubin & Rubin 1966) . Some children experienced slight nausea initially, but giving the drug as a single daily dose after the evening meal proved an effective remedy. No instances of prolonged leucopenia have been observed. Azathioprine, on the other hand, appears to cause more profound metabolic depression; the leucopenia which, in the case of cyclophosphamide, appears to be a useful therapeutic indicator, is often complicated by anemia, thrombocytopenia, hypoproteinmmia and stomatitis.
It may have been observed that I have avoided using the term 'immunosuppressive therapy'.
While the beneficial effects of cyclophosphamide in mice with autoimmune GN have been attributed to its lympholytic action (Russell et al. 1966 ), the most dramatic human results have occurred in that form of nephrotic syndrome, unaccompanied by severe proliferative and sclerosing glomerular changes, in which there is least evidence of immunological disturbance (Michael et al. 1964 ). Cytotoxic drugs also have an anti-inflammatory action (Page et al. 1962) but it is uncertain whether this or its immunosuppressive effect, or both, are operative in the diseases considered.
